These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20667296)

  • 41. Memantine (Namenda, Forest Pharmaceuticals).
    Roman MW
    Issues Ment Health Nurs; 2009 Mar; 30(3):202. PubMed ID: 19291500
    [No Abstract]   [Full Text] [Related]  

  • 42. Memantine: a new approach to Alzheimer's disease.
    Keltner NL; Williams B
    Perspect Psychiatr Care; 2004; 40(3):123-4. PubMed ID: 15515294
    [No Abstract]   [Full Text] [Related]  

  • 43. Common Alzheimer's drug flunks test of effectiveness. Initial improvements in cognitive ability made by cholinesterase inhibitors soon disappear.
    Health News; 2004 Oct; 10(10):11. PubMed ID: 15584119
    [No Abstract]   [Full Text] [Related]  

  • 44. Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study.
    Wroolie TE; Kenna HA; Williams KE; Powers BN; Holcomb M; Lazzeroni L; Rasgon NL
    Acta Neurol Scand; 2009 Mar; 119(3):172-9. PubMed ID: 18705678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease.
    Rabins PV; Lyketsos CG
    Nat Clin Pract Neurol; 2006 Nov; 2(11):578-9. PubMed ID: 17057739
    [No Abstract]   [Full Text] [Related]  

  • 46. Antimanic and long-lasting mood stabilizing effect of memantine in bipolar I mood disorder: two case reports.
    Serra G; De Chiara L; Koukopoulos A; Serra G
    J Clin Psychopharmacol; 2013 Oct; 33(5):715-7. PubMed ID: 24002206
    [No Abstract]   [Full Text] [Related]  

  • 47. Memantine hydrochloride.
    Witt A; Macdonald N; Kirkpatrick P
    Nat Rev Drug Discov; 2004 Feb; 3(2):109-10. PubMed ID: 15040575
    [No Abstract]   [Full Text] [Related]  

  • 48. Memantine (Namenda) for moderate to severe Alzheimer's disease.
    Ables AZ
    Am Fam Physician; 2004 Mar; 69(6):1491-2. PubMed ID: 15053415
    [No Abstract]   [Full Text] [Related]  

  • 49. Combination drug therapies for AD: progress is slow, but we must keep trying.
    Farlow MR
    Geriatrics; 2005 Jun; 60(6):13-4. PubMed ID: 15948660
    [No Abstract]   [Full Text] [Related]  

  • 50. Donepezil-induced nightmares in mild cognitive impairment.
    Kitabayashi Y; Ueda H; Tsuchida H; Yamashita T; Narumoto J; Fukui K
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):123-4. PubMed ID: 16472374
    [No Abstract]   [Full Text] [Related]  

  • 51. Memantine for treatment of moderate to severe Alzheimer's disease.
    Perras C
    Issues Emerg Health Technol; 2005 Mar; (64):1-4. PubMed ID: 15762015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug for moderate to advanced Alzheimer's approved.
    Mayo Clin Health Lett; 2004 Feb; 22(2):4. PubMed ID: 15032170
    [No Abstract]   [Full Text] [Related]  

  • 53. [[Donepezil : a new option in the treatment of Alzheimer's disease] ONEPA].
    Azanza JR; Sádaba B; Quetglas EG; Escolar M
    Rev Med Univ Navarra; 1998; 42(2):109-18. PubMed ID: 10420948
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of donepezil on the continuum of depressive symptoms, mild cognitive impairment, and progression to dementia.
    Panza F; Frisardi V; Capurso C; D'Introno A; Colacicco AM; Chiloiro R; Dellegrazie F; Di Palo A; Capurso A; Solfrizzi V
    J Am Geriatr Soc; 2010 Feb; 58(2):389-90. PubMed ID: 20370868
    [No Abstract]   [Full Text] [Related]  

  • 55. The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: findings from a 12-month naturalistic trial.
    Koukopoulos A; Serra G; Koukopoulos AE; Reginaldi D; Serra G
    J Affect Disord; 2012 Jan; 136(1-2):163-166. PubMed ID: 22030128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluconazole-carbamazepine interaction in a patient with bipolar disorder.
    Tsouli S; Maranis S; Kyritsis AP
    Psychiatry Clin Neurosci; 2011 Feb; 65(1):112. PubMed ID: 21265947
    [No Abstract]   [Full Text] [Related]  

  • 57. [Management of Alzheimer disease].
    Belmin J; Péquignot R; Konrat C; Pariel-Madjlessi S
    Presse Med; 2007 Oct; 36(10 Pt 2):1500-10. PubMed ID: 17601697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Memantine in the treatment and prophylaxis of bipolar type II mood disorder and co-morbid eating disorder: a case report.
    De Chiara L; Serra G; Koukopoulos AE; Koukopoulos A; Serra G
    Riv Psichiatr; 2014; 49(4):192-4. PubMed ID: 25174697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of subtle psychotic symptoms with memantine: a case report.
    Huey ED; Dustin IH; Overman GP; Mirza N; Sunderland T
    J Clin Psychiatry; 2005 May; 66(5):658-9. PubMed ID: 15889961
    [No Abstract]   [Full Text] [Related]  

  • 60. Memantine may acutely improve cognition and have a mood stabilizing effect in treatment-resistant bipolar disorder.
    Teng CT; Demetrio FN
    Braz J Psychiatry; 2006 Sep; 28(3):252-4. PubMed ID: 17063225
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.